Business & Finance AbbVie is buying a biotech company working on an experimental eczema drug for $10.9 billion
Apogee Therapeutics is developing a promising atopic dermatitis drug.
By
· June 22, 2026 · 1 min read
This article was originally published by
MarketWatch
and is republished here under license.
Apogee Therapeutics is developing a promising atopic dermatitis drug.
Related
Alan Greenspan presided over the Federal Reserve for 19 years under four presidents and mastered the art of obfuscation known…
By
· June 22, 2026 · 1 min read
JD Vance said U.S.-Iran talks in Switzerland made progress, with Tehran agreeing to allow IAEA inspectors back into Iran.…
By
· June 22, 2026 · 1 min read
Squeezed by stagnant wages, young Chinese are spending billions to buy “feelings.”…
By
· June 22, 2026 · 1 min read
Leave a Reply